Overview
Dr. Ross C. Donehower is an oncologist in the Baltimore area, caring for patients with gastrointestinal cancers. He was part of the team that developed premedications that allowed paclitaxel — a chemotherapy medication now used to treat several types of cancers — to be safely given to patients. The Virginia and D.K. Ludwig Professor in Clinical Investigation of Cancer, he serves as the director of the Hematology & Medical Oncology Fellowship Program and director of the Division of Medical Oncology at the Johns Hopkins School of Medicine. Dr. Donehower received his undergraduate degree from Hamline University and earned his M.D. from the University of Minnesota. He completed his residency at The Johns Hopkins Hospital. Dr. Donehower joined the Johns Hopkins faculty in 1980. Prior to joining Johns Hopkins, Dr. Donehower was a surgeon with the U.S. Public Health Service and a clinical associate of the medicine branch and clinical pharmacology branch at the National Cancer Institute. His research interests include gastrointestinal cancers, new anticancer drug development and pharmacology. Dr. Donehower serves on the editorial boards of numerous scholarly journals, including the International Journal of Oncology. He has been recognized by the American Society of Clinical Oncology with a 2017 Excellence in Teaching Award. He is a member of several professional organizations, including the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research.
Dr. Donehower is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Colorectal Cancer, Neuroendocrine Tumor, Familial Colorectal Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.
His clinical research consists of co-authoring 36 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10803 Falls Road, Pavilion III STE 1500, Pavilion III STE 1500, Lutherville, MD 21093
201 North Broadway Street, Viragh BLDG 5th FL, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Lutherville Hematology And Oncology Services
Sandy Kotiah is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Kotiah is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are Neuroendocrine Tumor, Paget Disease of the Breast, Anemia, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Kotiah is currently accepting new patients.
St Paul Place Specialists, Inc.
Panayotis Ledakis is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Ledakis is rated as an Elite provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Appendix Cancer, Desmoplastic Small Round Cell Tumor, Anemia, Colorectal Cancer, and Ureteroscopy. Dr. Ledakis is currently accepting new patients.
Inova Health Care Services
Timothy Cannon is an Oncologist and a Hematologist in Falls Church, Virginia. Dr. Cannon is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Cannon is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Donehower isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Donehower isDistinguished. Learn about Familial Colorectal Cancer.
- Neuroendocrine TumorDr. Donehower isDistinguished. Learn about Neuroendocrine Tumor.
- Advanced
- Familial Pancreatic CancerDr. Donehower isAdvanced. Learn about Familial Pancreatic Cancer.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Lynch SyndromeDr. Donehower isAdvanced. Learn about Lynch Syndrome.
- Pancreatic CancerDr. Donehower isAdvanced. Learn about Pancreatic Cancer.
- PancreaticoduodenectomyDr. Donehower isAdvanced. Learn about Pancreaticoduodenectomy.
- Experienced
- Ampullary CancerDr. Donehower isExperienced. Learn about Ampullary Cancer.
- Anal CancerDr. Donehower isExperienced. Learn about Anal Cancer.
- Appendix CancerDr. Donehower isExperienced. Learn about Appendix Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Donehower isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Fibrolamellar CarcinomaDr. Donehower isExperienced. Learn about Fibrolamellar Carcinoma.
- Gallbladder AdenocarcinomaDr. Donehower isExperienced. Learn about Gallbladder Adenocarcinoma.